Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Nicotine Dependence, Cigarettes: early-phase trial registry

2 of 4 indexed Nicotine Dependence, Cigarettes trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Nicotine Dependence, Cigarettes: 4 US clinical trials tracked, 2 recruiting.

Nicotine Dependence, Cigarettes is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Rowan University, running 1 of these trials.

Enrollment posture brief

Registry condition nicotine-dependence-cigarettes

OPEN 2 | RECR 50% | LATE 0 | EARLY 2 | RANK #4115 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Nicotine Dependence, Cig (th…50%
Open-enrollment share among volume-matched conditions near Nicotine Dependence, Cigarettes

Nicotine Dependence, Cigarettes lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Nicotine Dependence, Cigarettes on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Nicotine Dependence, Cigarettes is recruiting above its size-band peers.

    2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 21

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Named interventions

Most-linked intervention names on Nicotine Dependence, Cigarettes records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
2 trials
Web + text smoking cessation intervention Behavioral
1 trials
Varenicline (VRN) Drug
1 trials
N-Acetylcysteine (NAC) Drug
1 trials
Nicotine nasal spray 0.5 mg Drug
1 trials
Submission Contingent (SC) Re-Connect Behavioral
1 trials
Abstinent Contingent (AC) Re-Connect Behavioral
1 trials

US sites by state

Facility locations filed on Nicotine Dependence, Cigarettes trials. A trial with sites in several states counts in each.

Vermont 1 trials
South Carolina 1 trials
New Jersey 1 trials
North Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Nicotine Dependence, Cigarettes page

4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Nicotine Dependence, Cigarettes trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Rowan University sponsors the most Nicotine Dependence, Cigarettes trials on record, review their full trial history before evaluating a specific study. See Rowan University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Nicotine Dependence, Cigarettes condition card totals 4 registered trials; most-linked intervention Placebo; top US site state Vermont. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.